CURRENTGLOBAL Roche buys Roivant’s bowel disease drug for US$7.1blnEditor Selangor JournalOctober 23, 2023 by Editor Selangor JournalOctober 23, 2023 ZURICH/FRANKFURT, Oct 23 — Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial...